DIATOS

Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocellยฎ and Tumor-Selective Prodrug (TSP).
DIATOS
Industry:
Biotechnology Medical Therapeutics
Founded:
1999-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.diatos.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
12.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon
Similar Organizations
Biokinesis
Biokinesis is a biotechnology company developing new treatments for cancer by targeting a specific kinesin found in several cancers.
Elevar Therapeutics
Elevar Therapeutics is a pharmaceutical company that specializes in the development of therapies for unmet medical needs in cancer.
ImmunoGenes
ImmunoGenes is a biopharmaceutical company developing a platform which improves the immune system's response.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Neurophoenix
Neurophoenix is a biopharmaceutical company developing a new therapeutic solution for optic neuropathies.
NuCana BioMed
NuCana BioMed, a biopharmaceutical company, develops and commercializes rationally designed medicines for significant unmet medical needs.
Trophos
Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology
Investors List
Credit Agricole Entreprises
Credit Agricole Entreprises investment in Series D - Diatos
Idinvest Partners
Idinvest Partners investment in Series D - Diatos
Sopartec
Sopartec investment in Series D - Diatos
NIF SMBC Ventures
NIF SMBC Ventures investment in Series D - Diatos
Gimv
Gimv investment in Series D - Diatos
Biotech Fund Flanders
Biotech Fund Flanders investment in Series D - Diatos
Sofinnova Partners
Sofinnova Partners investment in Series D - Diatos
Innoven Partners
Innoven Partners investment in Series D - Diatos
Societe Generale Asset Management
Societe Generale Asset Management investment in Series D - Diatos
InterWest Partners
InterWest Partners investment in Series D - Diatos
Official Site Inspections
http://www.diatos.com
- Host name: ab791f743a3c6d593.awsglobalaccelerator.com
- IP address: 99.83.248.72
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
